TAIHO ONCOLOGY Logo (WIPO, 13.08.2014)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke TAIHO ONCOLOGY wurde als Bildmarke am 13.08.2014 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Kreise #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Ein Kreis #Kreise mit anderen figurativen Elementen #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1240551 |
| Länder | 
|
| Basismarke |
Nr. 2014-022682,
25. März 2014
|
| Anmeldedatum | 13. August 2014 |
| Ablaufdatum | 13. August 2024 |
Markeninhaber
1-27 Kandanishiki-cho,
Chiyoda-ku
JP
Chiyoda-ku
JP
Markenvertreter
Toranomon Mitsui Building 9F,
8-1, Kasumigaseki 3-chome,
JP
Waren und Dienstleistungen
05
Anti-cancer preparations and substances; anti-ulcerogenic
preparations and substances; pharmaceutical preparations and
substances for the treatment of immunological diseases;
pharmaceutical preparations and substances for the treatment
of urinary diseases; therapeutic preparations and substances
for pain; antiemetic preparations and substances; diagnostic
preparations and substances; drugs for genetic testing;
pharmaceutical preparations; dietary supplements for humans;
dietetic foods adapted for medical purposes
42
Scientific research for medical purposes in the field of
cancer, tumor, ulceration, immunological diseases, urinary
diseases, nausea, vomiting and pain; testing, inspection,
research or evaluation of pharmaceuticals, cosmetics or
foodstuff; advisory, consultancy or information services
relating to testing, inspection, research or evaluation of
pharmaceuticals, cosmetics or foodstuff; testing,
inspection, research or evaluation of medicine,
pharmaceutical preparations, medical activities or health
care; advisory, consultancy or information services relating
to testing, inspection, research or evaluation of medicine,
pharmaceutical preparations, medical activities or health
care; conducting clinical trials for pharmaceutical
products; providing information about the results of
clinical trials for pharmaceutical products; design and
development of computer hardware and software for use in the
field of medicine; research and development of medical
technology
44
Diagnostic services relating to cancer, tumor, ulceration,
immunological diseases, urinary diseases, nausea, vomiting
and pain; providing information relating to the treatment or
prevention of cancer, tumor, ulceration, immunological
diseases, urinary diseases, nausea, vomiting and pain;
consultation services relating to the treatment and
diagnosis of cancer, tumor, ulceration, immunological
diseases, urinary diseases, nausea, vomiting and pain;
medical counseling services relating to the treatment of
cancer, tumor, ulceration, immunological diseases, urinary
diseases, nausea, vomiting and pain; medical analysis
services and genetic testing for the diagnosis and prognosis
of the expected progression of cancer, tumor, ulceration,
immunological diseases, urinary diseases, nausea, vomiting
and pain; providing medical information relating to
efficacy, side effects, interactions of pharmaceuticals and
medication; collecting and managing clinical data relating
to clinical trials of pharmaceuticals; medical services;
providing medical information; physical examination;
dentistry; preparation and dispensing of medications
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Mai 2019 | 2019/22 Gaz | VN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 18. April 2019 | 2019/19 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| 20. April 2017 | 2017/16 Gaz | MX | Ablehnung |
| 25. Mai 2016 | 2016/26 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. März 2016 | 2016/18 Gaz | VN | Ablehnung |
| 28. Januar 2016 | 2016/5 Gaz | EM | Ablehnung |
| 20. Januar 2016 | 2016/5 Gaz | CN | Ablehnung |
| 01. Januar 2016 | 2016/3 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. November 2015 | 2015/50 Gaz | Korrektur | |
| 01. Oktober 2015 | 2015/40 Gaz | KR | Ablehnung |
| 11. Juli 2015 | 2015/31 Gaz | SG | Ablehnung |
| 13. August 2014 | 2015/11 Gaz | JP | Eintragung |
ID: 141240551